What is LEXX stock price today?

Visit our real-time dashboard for the current LEXX stock price and live market data.

Is LEXX stock going up or down today?

LEXX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy LEXX stock now?

The decision to buy LEXX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is LEXX a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for LEXX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is LEXX stock overvalued or undervalued?

Use our DCF valuation calculator to determine if LEXX is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is LEXX's P/E ratio?

P/E ratio data for LEXX will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is LEXX's market cap?

LEXX (Lexaria Bioscience Corp) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is LEXX's price to book ratio?

Price-to-book ratio for LEXX is available on our dashboard along with other valuation metrics.

Does LEXX pay dividends?

LEXX does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is LEXX's dividend yield?

LEXX does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is LEXX stock a good long-term investment?

LEXX's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is LEXX's revenue growth rate?

Revenue growth data for LEXX is available on our dashboard with detailed financial statement analysis.

Profitability metrics for LEXX are available on our dashboard with complete income statement analysis.

What are the risks of investing in LEXX?

Key risks for LEXX include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does LEXX compare to its competitors?

Compare LEXX to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize LEXX's performance and positioning.

What is LEXX's stock price target for 2026?

Visit our prediction page for AI-powered price targets for LEXX with bull, base, and bear case scenarios.

What do analysts say about LEXX?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for LEXX. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is LEXX's next earnings report?

LEXX reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

LEXX - Lexaria Bioscience Corp

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Lexaria Bioscience Corp

Lexaria Bioscience Corp (LEXX) common stock

Price Chart

Loading chart...

LEXX Key Statistics

Market Cap

$14.90M

How LEXX Compares to Peers

LEXX is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
LEXX(This stock)	$14.90M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 17, 2026 at 4:10 AM EDT

Ready to invest in LEXX?

Commission-free trading available. Affiliate links.

Upcoming Events for LEXX

Dashboard

Enter a ticker to analyze